Patents by Inventor Sophie COTE

Sophie COTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
    Publication number: 20110053903
    Abstract: A stable pharmaceutical composition comprising azetidine compound of formula (Ib): in a system comprising at most 2 principal excipients chosen from nonionic and hydrophilic surfactants capable of solubilizing the azetidine compound of formula (Ib) and, capable of causing the formation of a colloidal system, optionally supplemented with a second excipient of a lipophilic nature.
    Type: Application
    Filed: July 29, 2010
    Publication date: March 3, 2011
    Applicant: AVENTIS PHARMA SA
    Inventors: Sophie COTÉ, Valérie BOBINEAU, Maria-Teresa PERACCHIA
  • INJECTABLE OR ORALLY DELIVERABLE FORMULATIONS OF AZETIDINE DERIVATIVES
    Publication number: 20100022501
    Abstract: The invention concerns injectable or orally deliverable binary or ternary formulations of azetidine derivatives. The azetidine derivatives used in the inventive pharmaceutical compositions can be represented by the general formulae (Ia) or (Ib), wherein Ar is an aromatic or heteroaromatic group optionally substituted by one or more among (C1-C4)alkyl, halogen, NO2, CN, (C1-C4) alkoxy or OH.
    Type: Application
    Filed: October 5, 2009
    Publication date: January 28, 2010
    Applicant: AVENTIS PHARMA SA
    Inventors: Maria-Teresa PERACCHIA, Gilbert GAUDEL, Sophie COTE
  • SELF-EMULSIFYING AND SELF-MICROEMULSIFYING FORMULATIONS FOR THE ORAL ADMINISTRATION OF TAXOIDS
    Publication number: 20090069411
    Abstract: The present invention relates to novel formulations of taxoids for oral administration. More particularly, the present invention discloses and claims self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids.
    Type: Application
    Filed: September 26, 2008
    Publication date: March 12, 2009
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Maria-Teresa PERACCHIA, Sophie COTE, Gilbert GAUDEL
  • SEMI-SOLID SYSTEMS CONTAINING AZETIDINE DERIVATIVES
    Publication number: 20080293686
    Abstract: The present invention relates to novel formulations of azetidine derivatives for oral administration comprising at least one azetidine compound of formula (Ia) or (Ib): in a system comprising a Vitamin E d-?-tocopheryl polyethylene glycol 1000 succinate polymeric semi-solid material.
    Type: Application
    Filed: July 28, 2008
    Publication date: November 27, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Maria-Teresa PERACCHIA, Sophie COTE, Valerie BOBINEAU
  • INJECTABLE OR ORALLY DELIVERABLE FORMULATIONS OF AZETIDINE DERIVATIVES
    Publication number: 20070244085
    Abstract: The invention concerns injectable or orally deliverable binary or ternary formulations of azetidine derivatives. The azetidine derivatives used in the inventive pharmaceutical compositions can be represented by the general formulae (Ia) or (Ib), wherein Ar is an aromatic or heteroaromatic group optionally substituted by one or more among (C1-C4)alkyl, halogen, NO2, CN, (C1-C4) alkoxy or OH.
    Type: Application
    Filed: May 29, 2007
    Publication date: October 18, 2007
    Applicant: AVENTIS PHARMA SA
    Inventors: Maria-Teresa PERACCHIA, Gilbert GAUDEL, Sophie COTE
  • Pharmaceutical compositions based on azetidine derivatives
    Publication number: 20060166959
    Abstract: A stable pharmaceutical composition comprising azetidine compound of formula (Ib): in a system comprising at most 2 principal excipients chosen from nonionic and hydrophilic surfactants capable of solubilizing the azetidine compound of formula (Ib) and, capable of causing the formation of a colloidal system, optionally supplemented with a second excipient of a lipophilic nature.
    Type: Application
    Filed: March 29, 2006
    Publication date: July 27, 2006
    Applicant: Aventis Pharma S.A.
    Inventors: Sophie Cote, Valerie Bobineau, Maria-Teresa Peracchia
  • Emulsifying systems containing azetidine derivatives
    Publication number: 20050037062
    Abstract: The present invention relates to novel formulations of azetidine derivatives for oral administration.
    Type: Application
    Filed: July 13, 2004
    Publication date: February 17, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Sophie Cote, Maria-Teresa Peracchia, Valerie Bobineau
  • Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
    Publication number: 20050025792
    Abstract: The present invention relates to novel formulations of taxoids for oral administration. More particularly, the present invention discloses and claims self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids.
    Type: Application
    Filed: July 19, 2004
    Publication date: February 3, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Maria-Teresa Peracchia, Sophie Cote, Gilbert Gaudel
  • Semi-solid systems containing azetidine derivatives
    Publication number: 20050026898
    Abstract: The present invention relates to novel formulations of azetidine derivatives for oral administration.
    Type: Application
    Filed: July 13, 2004
    Publication date: February 3, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Maria-Teresa Peracchia, Sophie Cote, Valerie Bobineau
  • Pharmaceutical compositions based on azetidine derivatives
    Publication number: 20030139386
    Abstract: A stable pharmaceutical composition comprising at least one azetidine derivative of formula 1
    Type: Application
    Filed: December 20, 2002
    Publication date: July 24, 2003
    Inventors: Sophie Cote, Valerie Bobineau, Maria-Teresa Peracchia